Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
Medical Causes of Seizures
Lancet 352:383-390, Delanty,N.,et al, 1998
Prevalence of Cannabis Withdrawal Symptoms Among People with Regular or Dependent Use of Cannabinoids
JAMA doi:10.1001/JAMANETWORKOPEN.2020.2370, Bahji, A.,et al, 2020
Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Probably Medication-Overuse Headache: The Effect of a 2-Month Drug-Free Period
Neurol 66:1894-1898, Zeeberg,P.,et al, 2006
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Chronic headache:Appropriate Use of Opiate Analgesics
Neurol 44:S18-S24, Markley,H.G., 1994
Discontinuing Antiepileptic Drugs in Children with Epilepsy
NEJM 330:1407-1410, Tennison,M.,et al, 1994
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Abrupt Outpatient Withdrawal of Medication in Analgesic-Abusing Migraineurs
Lancet 337:1442-1443, Hering,T.&Steiner,T.J., 1991
Risk Associated with Heparin Withdrawal in Ischaemic Cerebrovascular Disease
JNNP 52:1332-1336, Slivka,A.,et al, 1989
Restless Legs
Lead Article BMJ 758, Dec1970., , 1970